MicroRNA-181a targets nanog in a subpopulation of CD34+ cells isolated from peripheral blood

Paul J. Mintz, Pål Sætrom, Vikash Reebye, Marie B. Lundbæk, Kaiqin Lao, John J. Rossi, Karin Ml Gaensler, Noriyuki Kasahara, Joanna P. Nicholls, Steen Jensen, Abdelali Haoudi, Mohamed Emara, Myrtle Ya Gordon, Nagy A. Habib

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Exploiting the properties of stem cells by microRNA (miRNA) profiling offers an attractive approach to identify new regulators of stem cell fate. Although numerous miRNA have been screened from hematopoietic stem cells (HSC), the targets corresponding to many of these miRNA have not yet been fully elucidated. By miRNA profiling in a subpopulation of CD34+ cells isolated from peripheral blood, we have identified eight clusters of miRNA that were differentially expressed. Further analysis of one of the clusters by bioinformatics revealed that a miRNA, miR-181a, which is highly expressed in the adherent CD34+ cells, affects the expression levels of Nanog, a stem cell surrogate marker. We show specifically by reporter assay and mutational analysis that miR-181a tazgets a seedless 3' compensatory site in the 3'UTR of Nanog and affects gene expression. We demonstrate that inhibiting miR-181a upregulates the Nanog expression level, in addition to an increase in alkaline phosphatase activity. Our studies suggest that miR-181a may be important in controlling the expression level of Nanog in a subpopulation of CD34+ cells.

Original languageEnglish
Article numbere34
JournalMolecular Therapy - Nucleic Acids
Volume1
DOIs
Publication statusPublished - 9 Nov 2012

Fingerprint

MicroRNAs
Stem Cells
3' Untranslated Regions
Hematopoietic Stem Cells
Computational Biology
Alkaline Phosphatase
Cluster Analysis
Up-Regulation
Biomarkers
Gene Expression

Keywords

  • CD34
  • MiR-181a
  • Nanog
  • Stem cells

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Mintz, P. J., Sætrom, P., Reebye, V., Lundbæk, M. B., Lao, K., Rossi, J. J., ... Habib, N. A. (2012). MicroRNA-181a targets nanog in a subpopulation of CD34+ cells isolated from peripheral blood. Molecular Therapy - Nucleic Acids, 1, [e34]. https://doi.org/10.1038/mtna.2012.29

MicroRNA-181a targets nanog in a subpopulation of CD34+ cells isolated from peripheral blood. / Mintz, Paul J.; Sætrom, Pål; Reebye, Vikash; Lundbæk, Marie B.; Lao, Kaiqin; Rossi, John J.; Gaensler, Karin Ml; Kasahara, Noriyuki; Nicholls, Joanna P.; Jensen, Steen; Haoudi, Abdelali; Emara, Mohamed; Gordon, Myrtle Ya; Habib, Nagy A.

In: Molecular Therapy - Nucleic Acids, Vol. 1, e34, 09.11.2012.

Research output: Contribution to journalArticle

Mintz, PJ, Sætrom, P, Reebye, V, Lundbæk, MB, Lao, K, Rossi, JJ, Gaensler, KM, Kasahara, N, Nicholls, JP, Jensen, S, Haoudi, A, Emara, M, Gordon, MY & Habib, NA 2012, 'MicroRNA-181a targets nanog in a subpopulation of CD34+ cells isolated from peripheral blood', Molecular Therapy - Nucleic Acids, vol. 1, e34. https://doi.org/10.1038/mtna.2012.29
Mintz, Paul J. ; Sætrom, Pål ; Reebye, Vikash ; Lundbæk, Marie B. ; Lao, Kaiqin ; Rossi, John J. ; Gaensler, Karin Ml ; Kasahara, Noriyuki ; Nicholls, Joanna P. ; Jensen, Steen ; Haoudi, Abdelali ; Emara, Mohamed ; Gordon, Myrtle Ya ; Habib, Nagy A. / MicroRNA-181a targets nanog in a subpopulation of CD34+ cells isolated from peripheral blood. In: Molecular Therapy - Nucleic Acids. 2012 ; Vol. 1.
@article{a76222b658ef4ca4969a75d72b6f9c7f,
title = "MicroRNA-181a targets nanog in a subpopulation of CD34+ cells isolated from peripheral blood",
abstract = "Exploiting the properties of stem cells by microRNA (miRNA) profiling offers an attractive approach to identify new regulators of stem cell fate. Although numerous miRNA have been screened from hematopoietic stem cells (HSC), the targets corresponding to many of these miRNA have not yet been fully elucidated. By miRNA profiling in a subpopulation of CD34+ cells isolated from peripheral blood, we have identified eight clusters of miRNA that were differentially expressed. Further analysis of one of the clusters by bioinformatics revealed that a miRNA, miR-181a, which is highly expressed in the adherent CD34+ cells, affects the expression levels of Nanog, a stem cell surrogate marker. We show specifically by reporter assay and mutational analysis that miR-181a tazgets a seedless 3' compensatory site in the 3'UTR of Nanog and affects gene expression. We demonstrate that inhibiting miR-181a upregulates the Nanog expression level, in addition to an increase in alkaline phosphatase activity. Our studies suggest that miR-181a may be important in controlling the expression level of Nanog in a subpopulation of CD34+ cells.",
keywords = "CD34, MiR-181a, Nanog, Stem cells",
author = "Mintz, {Paul J.} and P{\aa}l S{\ae}trom and Vikash Reebye and Lundb{\ae}k, {Marie B.} and Kaiqin Lao and Rossi, {John J.} and Gaensler, {Karin Ml} and Noriyuki Kasahara and Nicholls, {Joanna P.} and Steen Jensen and Abdelali Haoudi and Mohamed Emara and Gordon, {Myrtle Ya} and Habib, {Nagy A.}",
year = "2012",
month = "11",
day = "9",
doi = "10.1038/mtna.2012.29",
language = "English",
volume = "1",
journal = "Molecular Therapy - Nucleic Acids",
issn = "2162-2531",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - MicroRNA-181a targets nanog in a subpopulation of CD34+ cells isolated from peripheral blood

AU - Mintz, Paul J.

AU - Sætrom, Pål

AU - Reebye, Vikash

AU - Lundbæk, Marie B.

AU - Lao, Kaiqin

AU - Rossi, John J.

AU - Gaensler, Karin Ml

AU - Kasahara, Noriyuki

AU - Nicholls, Joanna P.

AU - Jensen, Steen

AU - Haoudi, Abdelali

AU - Emara, Mohamed

AU - Gordon, Myrtle Ya

AU - Habib, Nagy A.

PY - 2012/11/9

Y1 - 2012/11/9

N2 - Exploiting the properties of stem cells by microRNA (miRNA) profiling offers an attractive approach to identify new regulators of stem cell fate. Although numerous miRNA have been screened from hematopoietic stem cells (HSC), the targets corresponding to many of these miRNA have not yet been fully elucidated. By miRNA profiling in a subpopulation of CD34+ cells isolated from peripheral blood, we have identified eight clusters of miRNA that were differentially expressed. Further analysis of one of the clusters by bioinformatics revealed that a miRNA, miR-181a, which is highly expressed in the adherent CD34+ cells, affects the expression levels of Nanog, a stem cell surrogate marker. We show specifically by reporter assay and mutational analysis that miR-181a tazgets a seedless 3' compensatory site in the 3'UTR of Nanog and affects gene expression. We demonstrate that inhibiting miR-181a upregulates the Nanog expression level, in addition to an increase in alkaline phosphatase activity. Our studies suggest that miR-181a may be important in controlling the expression level of Nanog in a subpopulation of CD34+ cells.

AB - Exploiting the properties of stem cells by microRNA (miRNA) profiling offers an attractive approach to identify new regulators of stem cell fate. Although numerous miRNA have been screened from hematopoietic stem cells (HSC), the targets corresponding to many of these miRNA have not yet been fully elucidated. By miRNA profiling in a subpopulation of CD34+ cells isolated from peripheral blood, we have identified eight clusters of miRNA that were differentially expressed. Further analysis of one of the clusters by bioinformatics revealed that a miRNA, miR-181a, which is highly expressed in the adherent CD34+ cells, affects the expression levels of Nanog, a stem cell surrogate marker. We show specifically by reporter assay and mutational analysis that miR-181a tazgets a seedless 3' compensatory site in the 3'UTR of Nanog and affects gene expression. We demonstrate that inhibiting miR-181a upregulates the Nanog expression level, in addition to an increase in alkaline phosphatase activity. Our studies suggest that miR-181a may be important in controlling the expression level of Nanog in a subpopulation of CD34+ cells.

KW - CD34

KW - MiR-181a

KW - Nanog

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=84868371635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868371635&partnerID=8YFLogxK

U2 - 10.1038/mtna.2012.29

DO - 10.1038/mtna.2012.29

M3 - Article

VL - 1

JO - Molecular Therapy - Nucleic Acids

JF - Molecular Therapy - Nucleic Acids

SN - 2162-2531

M1 - e34

ER -